strong set-up upsid street
continu bullish baxter like set-up compani
report result thursday ok top-lin much better
bottom ep came street
estim despit headwind puerto rico sale increas
report organ organ ex-cyclo puerto rico guidanc also
look better expect compani initi outlook call ep
vs street consensu top-lin guidanc
organ ex-cyclo in-lin estim biggest take-away
multipl front top bottom-lin guidanc view look conserv
see top-lin upsid seri lever
drive bottom-lin beat -- margin expans tax capit deploy
buyback continu like set-up would buyer
stock current level
stock sold bit thursday primarili gain
ytd worth address coupl concern heard
day one set question center around guidanc baxter guid
impli fairli weak top-lin quarter specif report
constant currenc organ weak answer primarili
seri one-tim item biggest residu headwind
hurrican maria puerto rico headwind rel
one-tim transderm scop sale competitor recal baxter also
like see drop-off infus sale prior fda approv mid-
year launch next gener spectrum pump version said view
baxter guidanc conserv anticip top-lin acceler aid new
product launch eas comparison progress year
topic got attent thursday manag
margin guidanc ep guidanc came
street embed guidanc op margin expans
problem suggest surfac slowdown compani
margin momentum thing improv saw
vs moreov impli
necessari reacceler margin momentum baxter reach
margin target impli math annual
gain
page analyst certif import disclosur
 morgan seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report singl
factor make invest decis
dig beneath surfac bit youll see underli
margin improv guidanc actual far robust manag
guidanc look conserv starter baxter fairli conserv expect
cyclophosphamid assum new gener competit declin sale
result headwind margin think worst case scenaio expect
much modest declin like second baxter see plan step-down tsa
payment baxalta shire headwind margin third
adopt new pension account standard requir movement servic expens
relat inact employe oper line incom
headwind margin three item aggreg
headwind oper margin rel adjust item
improv
impli
that huge differ cast momentum baxter guid much
better light recogn well pension account chang geographi
profit move oper line cyclo guidanc
like conserv work
state earlier high confid baxter abil outperform
guidanc remind baxter earn back
headwind puerto rico guidanc call run rate
short baxter alreadi deliv rel guidanc see
top-lin upsid seri lever drive bottom-lin beat --
margin expans tax capit deploy buyback
invest thesi valuat risk
baxter turnaround stori play better expect think there still
plenti room go sinc take januari ceo almeida
transform compani low-margin low-fcf busi one that
significantli under-lev gener signific vs
expand oper margin two year baxter today
top-lin growth busi see upsid potenti opportun
achiev margin expans next year driven mix upgrad
gross margin improv exist busi control oper
spend that without put work underleverag balanc sheet
debt use drive earn power either accret
larg share buyback neither seem reflect street model
backdrop reiter overweight rate stock
dec price target valu baxter equal blend
ev/ebitda ep compar large-cap med-tech peer
ev/ebitda ep assum baxter trade par
peer ev/ebitda appropri given lower leverag level vs peer
modest premium ep due potenti upsid capit deploy
risk rate price
downsid risk includ manag inabl deliv margin expans
target misalloc balanc sheet potenti reimburs
price cut
baxter summari financi
cash equival
flow oper activ
o/w chang work capit
flow invest activ
sale
flow financ activ
net chang cash
adj free cash flow firm
compani report morgan estim
note million except per-shar data fiscal year end dec o/w
analyst certif research analyst denot ac cover report certifi multipl research
analyst primarili respons report research analyst denot ac cover within document
individu certifi respect secur issuer research analyst cover research view
express report accur reflect person view subject secur issuer part
research analyst compens directli indirectli relat specif recommend view
express research analyst report korea-bas research analyst list front cover also certifi per
kofia requir analysi made good faith view reflect opinion without undu influenc
